coronavirus vaccine development, the ICMR director general said three vaccines are at clinical trial stages in the country and two indigenously ones developed by Cadila and Bharat Biotech have completed phase-I trial.The results are being analysed and they have completed recruitment for the second phase, he said.Serum Institute of India has completed phase II-B3 trials of the Oxford COVID-19 vaccine candidate.